Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia.
Nülüfer KılıçGülay TaşcıSeda YılmazPınar ÖnerSevda KorkmazPublished in: Journal of personalized medicine (2023)
The elevated MHR in patients with schizophrenia may contribute to our understanding that inflammation plays important roles in the pathophysiology of schizophrenia. Additionally, knowing the levels of MHR and considering the recommendations, such as diet and exercise, in the treatment approaches made us think that it might be beneficial in protecting schizophrenia patients against cardiovascular diseases and early death.
Keyphrases
- bipolar disorder
- end stage renal disease
- oxidative stress
- cardiovascular disease
- physical activity
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- high intensity
- endothelial cells
- weight loss
- metabolic syndrome
- clinical practice
- immune response
- resistance training
- coronary artery disease
- body composition
- peripheral blood
- combination therapy
- patient reported